{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:41:59Z","timestamp":1648672919246},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.rce.2013.05.001","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T16:01:23Z","timestamp":1372694483000},"page":"388-393","source":"Crossref","is-referenced-by-count":2,"title":["Hipertensi\u00f3n arterial resistente"],"prefix":"10.1016","volume":"213","author":[{"given":"P.","family":"Armario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Oliveras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de la Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2013.05.001_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.rce.2011.09.010","article-title":"Determinaci\u00f3n de la excreci\u00f3n de alb\u00famina en la hipertensi\u00f3n arterial","volume":"212","author":"De la Sierra","year":"2012","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2013.05.001_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/jhh.2009.35","article-title":"Urinary albumin excretion is associated with true resistant hypertension","volume":"24","author":"Oliveras","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.rce.2011.07.013","article-title":"Enfermedad cardiovascular en pacientes con hipertensi\u00f3n arterial: diferencias por g\u00e9neros a partir de 100.000 historias cl\u00ednicas","volume":"212","author":"Gij\u00f3n-Conde","year":"2012","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2013.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A specific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0025","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"issue":"suppl 1","key":"10.1016\/j.rce.2013.05.001_bib0030","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/HJH.0b013e32835d2af0","article-title":"Clinical situations associated with difficult-to-control hypertension","volume":"31","author":"Oliveras","year":"2013","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.rce.2013.05.001_bib0035","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/HJH.0b013e32835d2c6c","article-title":"Therapeutic strategies to improve control of hypertension","volume":"31","author":"Armario","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0040","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/HJH.0b013e32834c465d","article-title":"Drug-related hypertension and resistance to antihypertensive treatment: A call for action","volume":"29","author":"Rossi","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2011.05.024","article-title":"Drug-induced hypertension: an unappreciated cause of secondary hypertension","volume":"125","author":"Grossman","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.rce.2013.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0b013e328353634e","article-title":"Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs","volume":"30","author":"De la Sierra","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0060","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2013.05.001_bib0065","doi-asserted-by":"crossref","first-page":"e7473","DOI":"10.1136\/bmj.e7473","article-title":"Resistant hypertension","volume":"345","author":"Myat","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.rce.2013.05.001_bib0070","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"De la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0075","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/archinte.168.21.2340","article-title":"Prognostic influence of office and ambulatory blood pressure in resistant hypertension","volume":"168","author":"Salles","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rce.2013.05.001_bib0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","article-title":"Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office and ambulatory blood pressure","volume":"47","author":"Ernst","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0085","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events. Systematic review and network meta-analysis","volume":"59","author":"Roush","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-7061(01)02342-1","article-title":"The role of spironolactone in the treatment of patients with refractory hypertension","volume":"15","author":"Ouzan","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","article-title":"Low-dose spironolactone in the management of resistant hypertension: A surveillance study","volume":"25","author":"Lane","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension","volume":"55","author":"De Souza","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jash.2010.10.001","article-title":"The effect of low-dose spironolactone on resistant hypertension","volume":"4","author":"Engbaek","year":"2010","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0120","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/HJH.0b013e32833d4c99","article-title":"Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system","volume":"28","author":"Alvarez-Alvarez","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0125","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT). A randomized, double-blind, placebo-controlled trial","volume":"57","author":"V\u00e1clav\u00edk","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0130","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rce.2013.05.001_bib0135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/HYPERTENSIONAHA.110.156976","article-title":"Divergent results using clinic and ambulatory blood pressures. Report of a Darusentan-Resistant Hypertension Trial","volume":"56","author":"Bakris","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2012.33","article-title":"Key advances in antihypertensive treatment","volume":"9","author":"Paulis","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.rce.2013.05.001_bib0145","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Efects of a novel aldosterone synthase inhibitor for treatment of primary hypertension. Results of a randomized, double-blind, placebo- an active-controlled phase 2 trial","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2013.05.001_bib0150","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehr253","article-title":"Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging dive-based approaches","volume":"32","author":"Unger","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2013.05.001_bib0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cjca.2011.11.005","article-title":"The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation","volume":"28","author":"Grassi","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.rce.2013.05.001_bib0160","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rce.2013.05.001_bib0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension. Durability of blood pressure reduction out to 24 months","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2013.05.001_bib0170","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.rce.2013.05.001_bib0175","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension. A pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2013.05.001_bib0180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rce.2013.05.001_bib0185","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJH.0b013e328352ce78","article-title":"ESH position paper: Renal denervation - an interventional therapy of resistant hypertension","volume":"30","author":"Schmieder","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht154","article-title":"Expert consensus document from the European Society of Cardiology on catheter-based renal denervation","author":"Mahfoud","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2013.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jacc.2010.03.089","article-title":"Novel baroreflex activation therapy in resistant hypertension","volume":"56","author":"Scheffers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rce.2013.05.001_bib0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","article-title":"Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial","volume":"58","author":"Bisognano","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rce.2013.05.001_bib0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jash.2012.01.003","article-title":"Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial","volume":"6","author":"Bakris","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.rce.2013.05.001_bib0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"J Am Soc Hypertens"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256513001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256513001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T18:23:28Z","timestamp":1539541408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256513001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0014256513001690"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2013.05.001","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}